| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |